International Immunology Advance Access originally published online on August 9, 2005
International Immunology 2005 17(9):1239-1248; doi:10.1093/intimm/dxh300
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysis
Department of Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel
Correspondence to: Z. Fishelson; E-mail: lifish{at}post.tau.ac.il
The membrane attack complex (MAC) of the complement system is causing membrane damage and cell death. For protection, cells have adopted several resistance mechanisms, including removal of the membrane-inserted MAC by vesiculation. To identify proteins involved in MAC vesiculation, extracellular proteins released from K562 cells in response to treatment with sub-lytic complement were separated by acrylamide gel electrophoresis and protein bands were extracted, digested into peptides and the peptides were analyzed by mass spectrometry. A 75-kDa protein that was abundant in the supernatant of complement-treated cells was identified as mortalin/GRP75. Analysis by western blotting demonstrated that as early as 5 min after exposure to sub-lytic doses of complement, mortalin was released from K562 cells. Mortalin was released after complete activation of the complement system and formation of C5b8, and even more so when C5b9 was formed. Other pore formers, such as streptolysin O and melittin, did not induce release of mortalin. As shown, mortalin can bind to complement C8 and C9 and is shed in vesicles containing C9 and complement MACs. Anti-mortalin antibodies reduced mortalin release from complement-treated cells and elevated the extent of cell death by complement. Inhibitors of protein kinase C and extracellular signal-regulated protein kinase also prevented mortalin release from complement-activated cells. These results suggest that mortalin/GRP75 promotes the shedding of membrane vesicles loaded with complement MAC and protects cells from complement-mediated lysis.
Keywords: C9, complement, membrane attack complex, membrane vesiculation, mortalin/GRP75
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Koch, M. Jung, R. Sabat, J. Kratzschmar, W.-D. Docke, K. Asadullah, H.-D. Volk, and G. Grutz IL-10 protects monocytes and macrophages from complement-mediated lysis J. Leukoc. Biol., July 1, 2009; 86(1): 155 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Beum, M. A. Lindorfer, F. Beurskens, P. T. Stukenberg, H. M. Lokhorst, A. W. Pawluczkowycz, P. W. H. I. Parren, J. G. J. van de Winkel, and R. P. Taylor Complement Activation on B Lymphocytes Opsonized with Rituximab or Ofatumumab Produces Substantial Changes in Membrane Structure Preceding Cell Lysis J. Immunol., July 1, 2008; 181(1): 822 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Moskovich and Z. Fishelson Live Cell Imaging of Outward and Inward Vesiculation Induced by the Complement C5b-9 Complex J. Biol. Chem., October 12, 2007; 282(41): 29977 - 29986. [Abstract] [Full Text] [PDF] |
||||


